Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190376 Anti-Aromatase composition
10/09/2003US20030190375 Therapeutical use of sophora flavescens or sophora subprostrata extracts
10/09/2003US20030190306 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/09/2003US20030190285 Having nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof; diagnostic and therapeutic applications
10/09/2003US20030188740 Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings
10/09/2003CA2519642A1 A composition and method for killing of tumours
10/09/2003CA2481795A1 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
10/09/2003CA2481304A1 Method for treating cancer in humans
10/09/2003CA2481253A1 Vegf peptides and their use
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2480694A1 Ox40r binding agents
10/09/2003CA2480686A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003CA2480679A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003CA2480661A1 A method of modulating cellular activity
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480635A1 Cancer associated protein kinases and their uses
10/09/2003CA2480632A1 Drug delivery particle
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2480263A1 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003CA2480128A1 Methods of using flt3-ligand in immunization protocols
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479763A1 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003CA2479495A1 Remedy for glioblastoma
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2478470A1 Solubilization of weak bases
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2474512A1 Method for producing pseudo islets
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350847A1 Human glioma antigen and process for preparing the same
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350794A1 Process for preparing substance gm-95
10/08/2003EP1350793A1 Medicinal compositions having improved absorbability
10/08/2003EP1350792A1 Medicinal compositions improved in solublity in water
10/08/2003EP1350521A1 Immunotherapeutic combinations for the treatment of tumors
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350514A2 Therapeutic use of cis-element decoys in vivo
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1350085A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
10/08/2003EP1349964A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests
10/08/2003EP1349963A2 Method for the determination of at least one functional polymorphism in the nucleotide sequence of a preselected candidate gene and its applications
10/08/2003EP1349962A1 Methods and compositions for detecting polynucleotide duplex damage
10/08/2003EP1349939A2 Aminoacyl trna synthetases
10/08/2003EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349927A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349919A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349871A2 Novel marker for the diagnosis and therapy of tumours
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349868A1 Process to concentrate insoluble proteins by vibrating membrane filtration
10/08/2003EP1349853A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349837A1 Antitumoral carbazoles
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349830A1 Tetralone derivatives as antitumor agents
10/08/2003EP1349614A2 Compounds regulating cell proliferation and differentiation
10/08/2003EP1349576A2 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological di
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349568A1 Immunomodulatory constructs and their uses
10/08/2003EP1349567A1 Compositions containing gangliosides for use in the treatment of skin disorders
10/08/2003EP1349565A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349557A2 Fractions of snake blood, their preparation and use as therapeutic agents
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1349545A1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1150683B1 Utilization of dienogest in high doses
10/08/2003EP1144421B1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
10/08/2003EP1070068B1 Granulatimide derivatives for use in cancer treatment
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0920523B1 Hsv strain lacking functional icp27 and icp34.5 genes
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2
10/08/2003EP0812319B9 2-arylbenzazole compounds
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447920A Compsns. and methods for modulating tumor specific expression
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447805A Novel indole derivatives and their use as medicaments
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447796A Novel heteroaryl derivatives and use thereof as anti-tumour agents
1 ... 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 ... 2211